To confirm the tumor-initiating capabilities, both the stable clones of the IL-33-overexpressing FaDu cells and the control cells were injected subcutaneously into BALB/c nude mice, and the tumorigenicity of the transplants was analyzed. The gene discussed is IL33; the disease is neoplasm.